Autophagy regulation as a promising approach for improving cancer immunotherapy

被引:29
|
作者
Ishimwe, Nestor [1 ,2 ,3 ]
Zhang, Wenbin [2 ,3 ]
Qian, Jieying [2 ,3 ]
Zhang, Yunjiao [2 ,3 ,4 ,5 ,6 ]
Wen, Longping [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China
[2] South China Univ Technol, Guangzhou Peoples Hosp 1, Sch Med, Guangzhou 510006, Guangdong, Peoples R China
[3] South China Univ Technol, Inst Life Sci, Guangzhou 510006, Guangdong, Peoples R China
[4] Natl Engn Res Ctr Tissue Restorat & Reconstruct, Guangzhou 510006, Guangdong, Peoples R China
[5] Key Lab Biomed Engn Guangdong Prov, Guangzhou 510006, Guangdong, Peoples R China
[6] Innovat Ctr Tissue Restorat & Reconstruct, Guangzhou 510006, Guangdong, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
Autophagy modulation; Immunogenic cell death; Cytotoxic T lymphocyte; Immune response; Tumor microenvironment; IMMUNOGENIC CELL-DEATH; T-CELLS; CALRETICULIN EXPOSURE; CROSS-PRESENTATION; SUPPRESSOR-CELLS; IMMUNE-RESPONSES; METABOLISM; SURVIVAL; STAT3; HYDROXYCHLOROQUINE;
D O I
10.1016/j.canlet.2020.01.034
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Autophagy plays a critical role in intracellular metabolism and maintaining cellular homeostasis. Certain tumor cells present a higher basal autophagy rate and autophagy inhibition can lead to impaired metabolic dysfunction in autophagy-dependent tumor cells. Autophagy status in immune cells dictates their fate and response to antigen; however, autophagy in immune cells may be beneficial or detrimental depending on the developmental stage of the cell and more specifically its degree of differentiation. Autophagy-deficient hosts present variations in many metabolites, proteins and enzymes that may have tumor-promoting or -inhibiting effects. The centrality of autophagy in the metabolism of some cancers and immune cells poses as a critical target whose mechanisms must be further unraveled to optimize patient response and prevent tumor recurrence.
引用
收藏
页码:34 / 42
页数:9
相关论文
共 50 条
  • [21] Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy
    Mehregan Babamohamadi
    Nastaran Mohammadi
    Elham Faryadi
    Maryam Haddadi
    Amirhossein Merati
    Farbod Ghobadinezhad
    Roshanak Amirian
    Zhila Izadi
    Jamshid Hadjati
    Cell Death & Disease, 15
  • [22] Regulation of autophagy fires up the cold tumor microenvironment to improve cancer immunotherapy
    Jin, Zhicheng
    Sun, Xuefeng
    Wang, Yaoyao
    Zhou, Chao
    Yang, Haihua
    Zhou, Suna
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [23] Immunotherapy: a promising approach for glioma treatment
    Yasinjan, Feroza
    Xing, Yang
    Geng, Huayue
    Guo, Rui
    Yang, Lei
    Liu, Ziling
    Wang, Hong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [24] Cancer immunotherapy: a promising dawn in cancer research
    Bondhopadhyay, Banashree
    Sisodiya, Sandeep
    Chikara, Atul
    Khan, Asiya
    Tanwar, Pranay
    Afroze, Dil
    Singh, Neha
    Agrawal, Usha
    Mehrotra, Ravi
    Hussain, Showket
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2020, 10 (06): : 375 - 385
  • [25] Dual inhibition of BDNF/TrkB and autophagy: a promising therapeutic approach for colorectal cancer
    Mazouffre, Clement
    Geyl, Sophie
    Perraud, Aurelie
    Blondy, Sabrina
    Jauberteau, Marie-Odile
    Mathonnet, Muriel
    Verdier, Mireille
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2017, 21 (10) : 2610 - 2622
  • [26] Blockade of the CD47-SIRPα axis: a promising approach for cancer immunotherapy
    Uger, Robert
    Johnson, Lisa
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (01) : 5 - 8
  • [27] CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities
    Akhoundi, Maryam
    Mohammadi, Mahsa
    Sahraei, Seyedeh Saeideh
    Sheykhhasan, Mohsen
    Fayazi, Nashmin
    CELLULAR ONCOLOGY, 2021, 44 (03) : 495 - 523
  • [28] CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities
    Maryam Akhoundi
    Mahsa Mohammadi
    Seyedeh Saeideh Sahraei
    Mohsen Sheykhhasan
    Nashmin Fayazi
    Cellular Oncology, 2021, 44 : 495 - 523
  • [29] mRNA: A promising platform for cancer immunotherapy
    Kong, Byoungjae
    Kim, Yelee
    Kim, Eun Hye
    Suk, Jung Soo
    Yang, Yoosoo
    ADVANCED DRUG DELIVERY REVIEWS, 2023, 199
  • [30] VISTA: A Promising Target for Cancer Immunotherapy?
    Tagliamento, Marco
    Agostinetto, Elisa
    Borea, Roberto
    Brandao, Mariana
    Poggio, Francesca
    Addeo, Alfredo
    Lambertini, Matteo
    IMMUNOTARGETS AND THERAPY, 2021, 10 : 185 - 200